Abstract
Chloroquine-resistant Plasmodium strains are found in certain foci in Cameroon. We do not know what contribution drug prescriptions and drug pressure had in bringing this about. We contacted 66 persons (39 doctors and 27 nurses) who prescribe antimalarial drugs in Cameroon regarding their prescription habits; 46 (69.7%) responded. The three most prescribed drugs for uncomplicated malaria were quinine (84.4%), chloroquine (80.4%) and amodiaquine (80.4%). The most common reason for prescribing the drugs was availability. The drug of choice for the treatment of uncomplicated malaria was chloroquine with amodiaquine and quinine being second best for doctors and nurses, respectively. The form of treatment preferred by most doctors (ie 46%) was tablets while most nurses (42%) preferred injections.
Prophylatic antimalarials were prescribed by 73% of the doctors and by 83% of the nurses. Doctors prescribed mainly to children and pregnant women while nurses prescribed to everyone. The drugs used were chloroquine, amodiaquine, quinine and pyrimethamine. Ten doctors and four nurses had encountered at least one case of drug resistant malaria. The most common evidence on which the diagnosis had been based was the absence of improvement on the treatment prescribed. The implicated drugs were chloroquine, amodiaquine and quinine.
There was evidence of major differences in the practice of the respondents regarding treatment, prophylaxis and the diagnosis of drug resistance. These results indicate an urgent need for a national antimalarial drug policy in Cameroon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ambroise-Thomas P. and Rossignol J.F. (1986): Chemotheraphy of resistant falciparum malaria. -Parasitol Today, 2: 79–80.
Bradley-Moore A.M., Greenwood B.M., Bradley A.K., Akintunde A., Attai E.D.E., Fleming A.F., Bartlett A., Bidwell D.E., Voller A., Kirkwood B.R. and Gilles H.M. (1985): A comparison of chloroquine and pyrimethamine as malaria chemoprophylaxis in young Nigerian children. - Trans Roy Soc. Trop. Med. Hyg., 79: 722–727.
Brasseur P., Druilhe P., Kouamouo J., Brandicourt O., Danis M. and Moyou R. (1986): High level of sensivity to chloroquine of 72 Plasmodium falciparum isolates from Southern Cameroon in January 1985. - J. Trop. Med. Hyg., 35: 711–716.
Bunnag D. and Harinasuta T. (1987): The current status of drug resistance in Malaria. - Int. J. Parasitol, 17: 169–180.
Campbell C.C., Chin W., Collins W.E., Teutsch S.M. and Moss D.M. (1979): Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensivity of the Tanzanian I/CDC strain from an American tourist. - Lancet, 2: 1151–1154.
Heymann D.L., Khoromana C.O., Wirima J.J. and Campbell C.C. (1987): Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi. - Trans. Roy Soc. Trop. Med. Hyg., 81: 722–724.
Jackson D.V., Marcarelli P. and Segal G. (1987): Chloroquine resistant Plasmodium falciparum in West Africa. - MMWR, 36: 13–14.
Laing A.B.G. (1984): The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon and Senegal. - Bull. WHO, 62: 41–48.
LeBras J., Hatu I., Bourée P., Coco-Cianci O., Garin J.-P., Rey M., Charmot G. and Roue R. (1986): Chloroquine-resistant falciparum malaria in Benin. -Lancet, 2: 1043–1044.
Menon A., Snow R.W., Otoo L. and Greenwood B.M. (1987): Decline in sensitivity of Plasmodium falciparum to chloroquine in the Gambia. - Lancet, 1: 1029–1030.
Moore D.V. and Lanier J.E. (1981): Observations on two Plasmodium falciparum infections with abnormal response to chloroquine. - Am. J. Trop. Med. Hyg., 10: 5–9.
Neequaye J. (1986): In vivo chloroquine resistant falciparum malaria in western Africa. - Lancet, 1: 153.
Payne D. (1987): Spread of chloroquine resistance in Plasmodium falciparum. - Parasitol. Today, 3: 241–246.
Peto T.E.A. and Gilks C.F. (1986): Amodiaquine and malaria prophylaxis. - Parasitol. Today, 2: 209–211.
Phillpson J.D. andO'Neill M.J. (1986): Novel antimalarial drugs from plants? - Parasitol Today, 2: 355–358.
Raccurt C.P., LeBras J., Beylet J., Combe A. and Ripert C. (1986): Cas fatal de neuropaludisme chloroquine-resistant chez un voyageur au Cameroon. - Bull. Soc. Path. Exot. Fd., 79: 39–40.
Salako L.A. and Aderounmu A.F. (1987): In-vitro chloroquine and mefloquine-resistant Plasmodium falciparum in Nigeria. - Lancet, 1: 572–573.
Sansonetti P.J., LeBras J., Verdier F., Charmot G., Dupont B. and Lapresle C. (1985): Chloroquine-resistant Plasmodium falciparum in Cameroon. -Lancet, 1: 1151–1155.
Spencer H.C. (1985): Drug-resistant malaria-changing patterns mean difficult decisions. - Trans. Roy Soc. Trop. Med. Hyg., 79: 748–758.
Wernsdorfer W.H. (1986): Current approaches to malaria chemotherapy and prophylaxis. - Parasitol. Today, 2: 250–253.
Wernsdorfer W.H. and Kouznetsov R.L. (1980): Drug resistant malaria-occurrence and surveillance. - Bull. WHO, 58: 341–352.
World Health Organization (1967): Chemotherapy of malaria. Report of a WHO Scientific Group. - WHO Technical Report Series no. 375, Geneva.
23.World Health Organization (1982): Instructions for the use of the microtest kit for the assessment of the response to chloroquine and mefloquine (WHO/ MAP/82.1). - WHO, Geneva.
World Health Organization (1984): Advances in malaria cchemotherapy. Report of a WHO Scientific Group. - WHO Technical Report Series no. 711, Geneva.
Author information
Authors and Affiliations
Additional information
Based on a talk delivered at the second Franco-Cameroonian Medical Meeting on 20 and 23 October 1987 in Yaounde and Douala, Cameroon.